Table 2.
Correlations between s-Podxl concentration and other clinical parameters.
| n | r | p | |
|---|---|---|---|
| Age (yrs) | 52 | −0.10 | 0.4958 |
| BMI (kg/m2) | 52 | −0.13 | 0.3425 |
| sBP (mmHg) | 52 | 0.12 | 0.4150 |
| dBP (mmHg) | 52 | −0.10 | 0.4986 |
| Pulse pressure (mmHg) | 52 | 0.28 | 0.0420 |
| LDL-C (mg/dL) | 52 | −0.05 | 0.7214 |
| HDL-C (mg/dL) | 52 | −0.36 | 0.0087 |
| TG (mg/dL) | 52 | 0.17 | 0.2200 |
| HbA1c (%) | 52 | 0.19 | 0.1800 |
| CPR index (before meals) | 52 | −0.17 | 0.2236 |
| ABI | 52 | −0.17 | 0.2304 |
| baPWV (cm/s) | 52 | 0.16 | 0.2438 |
| FMD (%) | 39 | 0.20 | 0.2109 |
| IMT (mm) | 52 | 0.30 | 0.0307 |
| eGFR (ml/min/1.73 m2) | 52 | 0.18 | 0.2013 |
| EPA/AA | 52 | −0.25 | 0.0700 |
| hs-CRP (ng/dL) | 52 | 0.10 | 0.5003 |
| MDA-LDL (mg/dL) | 52 | 0.11 | 0.4344 |
(Spearman’s rank correlation coefficient). EPA/AA: eicosapentaenoic acid to arachidonic acid ratio, mdaLDL: malondialdehyde modified Low density lipoprotein.